Does BPC-157 Help Climber's Elbow?

Does BPC-157 help climber’s elbow? It’s an open debate, not a settled thing. Climbers who use it say the peptide quiets the inner-elbow tendon pain and gets them back on the wall sooner — the idea being that BPC-157 speeds soft-tissue healing. Others aren’t sold: they say the hype rides on animal studies rather than climbers, and that it did nothing for their elbow. This post lays out both cases — plus the wrinkle that “climber’s elbow” is really two different injuries people mix up.

The full rundown — the two injuries, the case for BPC-157, and the case against ↓

What is climber’s elbow?

The two patterns:

  • Medial epicondylitis — pain where the wrist and finger flexor tendons attach to the inner elbow. It’s the same injury golfers get. Crimping and pulling load these tendons over and over.
  • Brachialis strain — pain deeper and toward the front of the elbow, often from dynamic moves, campus boarding, or a hard catch on a dyno.

Despite the “-itis” in the name, this usually isn’t inflammation:

  • In chronic cases the tendon breaks down and rebuilds poorly — a process called tendinosis, not tendinitis.
  • A 2009 review described it as a continuum — a tendon slides from a reactive, still-recoverable stage through “dysrepair” toward truly degenerative tissue.[2]
  • That’s a big part of why rest alone often doesn’t fix a stubborn elbow: degenerative tendon responds to load, not just time off.

What are BPC-157 and TB-500?

  • BPC-157 is a lab-made peptide sold online for tissue repair. The name is short for “Body Protection Compound,” and its recipe comes from a protein found in human stomach fluid.
  • TB-500 is usually sold with it — the Wolverine stack. It’s a lab-made fragment of a natural protein called thymosin β4, whose wound-healing and cell-movement activity is documented in the research,[3] and which has been through human trials for dry eye, given as an eye drop.[4]

Why do climbers use it for elbow pain?

The logic is simple: a stubborn elbow tendon is a repair problem, and BPC-157 is described in lab research as acting on the machinery repair depends on. The specific claims:

  • Tendon cell growth. A 2011 lab study found BPC-157 helped tendon cells (tenocytes) move, grow, and survive stress in a dish.[7]
  • Growth-hormone sensitivity. A 2014 lab study found it increased growth-hormone receptors on those same tendon cells.[8]
  • New blood vessels. Part of the reasoning is angiogenesis — growing new blood vessels. On the Huberman Lab podcast, that effect was described as its proposed healing mechanism[14] — appealing because tendon heals slowly partly for lack of blood supply.
  • Healing a cut tendon. A 2006 rat study found BPC-157 helped a surgically cut Achilles tendon heal, and offset the healing delay steroids normally cause.[6]
  • The TB-500 angle. Thymosin β4, the protein it’s a fragment of, is described in the research as driving cell movement and wound repair[3] — and users apply that to tendon.

What climbers actually use it for, going by their posts:

  • Medial epicondylitis or golfer’s elbow that hasn’t resolved with rest.
  • Brachialis pain.
  • Most often, an elbow that’s already been sore for months and hasn’t responded to a layoff.

How do people use it?

  • On forums like MESO-Rx, users describe injecting BPC-157 — often stacked with TB-500 — for tendon and joint pain, including the elbow.[5]
  • The recurring worry is whether the vial they bought actually contains what the label says.

What do users report?

  • On MESO-Rx, one user logged a TB-500 cycle and reported little effect until week four, when a golfer’s-elbow injury started resolving faster, alongside more visible veins.[11]
  • Reports on BPC-157 specifically are mixed — some describe fast relief; others say it did nothing, and both forums flag how often the product is fake or underdosed.[5][12]

What some users report (anecdotal)

  • Faster elbow pain relief
  • Less stiffness
  • More visible veins
  • Quicker return to climbing

What other users report (anecdotal)

  • No effect at all
  • Wasted money on fakes
  • Doubts it did anything

Two things worth keeping in mind:

  • These are self-selected reports from anonymous posters, not measured outcomes.
  • Elbow injuries change on their own over time, and BPC-157 and TB-500 are almost always used together — so a report rarely separates one from the other.

What side effects are reported?

Neither BPC-157 nor TB-500 has a formal human safety study, so there’s no official side-effect list — just forum reports and expert caution.

Reported by forum users (anecdotal)

  • Injection-site pain
  • Redness, flushing
  • Nausea
  • Heart palpitations
  • Fatigue, lethargy
  • Headaches
  • Mood changes
  • Metallic taste
  • Under-eye puffiness
  • Temporary bicep soreness

Off-label upsides some users report (anecdotal)

  • Better mood
  • Less anxiety
  • Hair growth
  • Better skin
  • More flexibility

A few specifics from the forums:

  • Users on Reddit’s r/bpc_157, r/Peptides, and r/TBI describe heart palpitations and jumps in resting heart rate after BPC-157, sometimes with chest pain — one, stacking it with TB-500, posted “BPC 157 giving me palpitations and anxiety?” after weeks of daily use.
  • TB-500 users raise a theoretical worry tied to its own mechanism: it promotes angiogenesis (new blood-vessel growth), which is how it’s thought to help tissue heal — but that same mechanism is the basis for a concern that it could feed an undetected tumor. This hasn’t been shown to cause cancer in people; the concern is mechanistic, not a reported outcome.
  • Purity varies between sellers — gray-market testing has found some material as low as about 55% pure.

And from people with a public platform:

  • Physician Peter Attia puts BPC-157 in his lowest-confidence group, noting its animal results haven’t been repeated in people.[13]
  • On the Huberman Lab podcast, the main concerns raised were product sourcing and a theoretical cancer risk, since BPC-157 can promote blood-vessel growth.[14]
  • In 2023, the FDA placed BPC-157 in a restricted compounding category, alongside 18 other peptides, citing concerns like immune reactions and impurities.[15]

What’s the standard approach to climber’s elbow?

For context on what a peptide would sit alongside or instead of:

  • Tell the two injuries apart. Medial epicondylitis and brachialis strain need different rehab, and treating both as generic “elbow tendinitis” is a common reason recovery stalls.
  • Load it, don’t just rest it. Because chronic tendon pain is degenerative, gradual load is what drives repair.[2]
  • Slow, heavy loading has a track record. The original research on heavy, eccentric loading returned every subject in a small study to full activity in twelve weeks — for the Achilles, though the same principle is applied to the elbow.[16]
  • Load the opposite muscles too. A common climbing-specific add-on is training the antagonists — the wrist and finger extensors on the back of the forearm — often as antagonist supersets, to balance out all the pulling that loads the flexor side.
  • Time. Degenerative tendon builds slowly and resolves slowly.

What do the studies say?

No study — human or animal — has tested BPC-157 or TB-500 on climber’s elbow. The research the theory rests on is about a different tendon, in a different species:

  • A 2006 rat study found BPC-157 helped a surgically cut Achilles tendon heal, and offset the healing delay steroids normally cause.[6]
  • A 2011 lab study found it helped tendon cells move, grow, and survive stress in a dish.[7]
  • A 2014 lab study found it increased growth-hormone receptors on those same tendon cells.[8]
  • A 2025 review found 35 animal studies and one human study — a small case series on knee pain, not a controlled trial, and nothing about elbows.[1]
  • A separate 2025 review reported human data are “extremely limited,” with most research coming from a single lab.[9]
  • TB-500 has no human trial of its own; the human trials of thymosin β4, the protein it’s a fragment of, are for dry eye and use an eye drop.[4]

What about PRP?

Platelet-rich plasma (PRP) — a shot made from a patient’s own blood — comes up often as the comparison, because it’s the injectable that has been through controlled human trials for elbow tendon pain (specifically lateral epicondylitis, or tennis elbow — the outer-elbow version of what most climbers get). A meta-analysis of those trials found PRP was not reliably better than a placebo shot for pain or function.[10]

Bottom line

  • Climbers use BPC-157 and TB-500 for a stubborn elbow on the strength of the lab work — tendon-cell growth, new blood vessels, and a rat Achilles that healed faster.
  • What users report is mixed, and the two are nearly always taken together.
  • No study has tested either one on an elbow, in people or animals — what exists is animal and cell-culture work.
  • The alternative climbers usually get steered to is progressive loading.

Frequently asked questions

Why do climbers use BPC-157 for elbow pain?
The reasoning comes from lab and animal work: BPC-157 has been reported to help tendon cells grow and migrate in a dish, and to speed healing in a cut rat Achilles tendon. Climbers apply that reasoning to a tendon injury that’s slow to resolve.
Has BPC-157 been studied for climber's elbow?
No. A 2025 review of BPC-157 research found no completed human trial for any elbow tendon condition. The research that exists is a rat Achilles-tendon study and cell-culture work.
Is climber's elbow the same as golfer's elbow?
Often, yes — both usually describe medial epicondylitis, pain where the wrist and finger flexor tendons meet the inner elbow. Climbers also get a second pattern, brachialis strain, from dynamic moves like campus boarding, which needs different rehab.
What has PRP shown for elbow tendon pain?
PRP has been tested in controlled human trials for elbow tendon pain. A meta-analysis of those trials found it was not reliably better than a placebo shot for pain or function. BPC-157 and TB-500 have not been tested on an elbow in any trial.
What's the standard approach to a climber's elbow that won't heal?
Clinicians generally start by confirming which of the two injuries it is, then use a progressive loading program — the eccentric and slow, heavy-loading approach studied in chronic Achilles tendons.
What human data exists on TB-500?
None for tendons. TB-500 is a fragment of thymosin β4, a protein whose human trials are for dry eye, delivered as an eye drop. TB-500 itself has no human trial data.

References

  1. Vasireddi N, Hahamyan H, Salata MJ, et al. Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review. HSS J. 2025. PMID: 40756949. DOI: 10.1177/15563316251355551.
  2. Cook JL, Purdam CR. Is tendon pathology a continuum? A pathology model to explain the clinical presentation of load-induced tendinopathy. Br J Sports Med. 2009. PMID: 18812414. DOI: 10.1136/bjsm.2008.051193.
  3. Goldstein AL, Hannappel E, Kleinman HK. Thymosin beta4: actin-sequestering protein moonlights to repair injured tissues. Trends Mol Med. 2005. PMID: 16099219. DOI: 10.1016/j.molmed.2005.07.004.
  4. RegeneRx Biopharmaceuticals (RGN-259 program). Thymosin β4 ophthalmic solution (RGN-259) in dry eye: randomized controlled trial. Clin Ophthalmol. 2015. DOI: 10.2147/OPTH.S80954.
  5. MESO-Rx forum members BPC-157 — community discussion thread MESO-Rx forum. n.d.. Source.
  6. Krivic A, Anic T, Seiwerth S, Huljev D, Sikiric P. Achilles detachment in rat and stable gastric pentadecapeptide BPC 157: promoted tendon-to-bone healing and opposed corticosteroid aggravation. J Orthop Res. 2006. PMID: 16583442. DOI: 10.1002/jor.20096.
  7. Chang CH, Tsai WC, Lin MS, Hsu YH, Pang JH. The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration. J Appl Physiol. 2011. PMID: 21148156. DOI: 10.1152/japplphysiol.00945.2010.
  8. Chang CH, Tsai WC, Hsu YH, Pang JH. Pentadecapeptide BPC 157 enhances the growth hormone receptor expression in tendon fibroblasts. Molecules. 2014. PMID: 25415472. DOI: 10.3390/molecules191119066.
  9. Regeneration or Risk? A Narrative Review of BPC-157 for Musculoskeletal Healing. Curr Rev Musculoskelet Med. 2025. DOI: 10.1007/s12178-025-09990-7.
  10. Platelet-rich plasma versus placebo for lateral epicondylitis: a systematic review and meta-analysis. Clin Rheumatol. 2020. DOI: 10.1007/s10067-020-05000-y.
  11. MESO-Rx forum member TB-500 cycle — user log MESO-Rx forum. n.d.. Source.
  12. LongeCity forum members BPC-157 — community megathread LongeCity forum. n.d.. Source.
  13. Attia P AMA #83: Peptides — evaluating the science, safety, and hype The Peter Attia Drive (podcast). n.d.. Source.
  14. Huberman A Benefits & Risks of Peptide Therapeutics for Physical & Mental Health Huberman Lab (podcast). n.d.. Source.
  15. U.S. Food and Drug Administration 19 peptides placed in Category 2 of the interim 503A bulks list (safety concerns: immunogenicity, peptide-related impurities) FDA regulatory action, Sept 29, 2023. 2023. Source.
  16. Alfredson H, Pietilä T, Jonsson P, Lorentzon R. Heavy-load eccentric calf muscle training for the treatment of chronic Achilles tendinosis. Am J Sports Med. 1998. PMID: 9617396. DOI: 10.1177/03635465980260030301.